These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18592985)

  • 21. Pulmonary lymphangioleiomyomatosis: a case report in postmenopausal woman treated with pleurodesis and progesterone (medroxyprogesterone acetate).
    Zanella A; Toppan P; Nitti D; Lise M
    Tumori; 1996; 82(1):96-8. PubMed ID: 8623516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does needle size matter? Patient experience of luteinising hormone-releasing hormone analogue injection.
    Montgomery BS; Borwell JP; Higgins DM
    Prostate Cancer Prostatic Dis; 2005; 8(1):66-8. PubMed ID: 15700050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pulmonary lymphangioleiomyomatosis and sex hormones].
    Battesti JP; Pechnick B; Kambouchner M
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):761-3. PubMed ID: 8308203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Skin reaction induced by subcutaneous injection of LH-RH analogue].
    Segawa N; Nishida T; Hamada S; Azuma H; Katsuoka Y; Nozaki K; Tsuji M
    Hinyokika Kiyo; 2007 Oct; 53(10):695-8. PubMed ID: 18018584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fertility preservation in (breast) cancer patients: is it safe?
    Wildiers H; Neven P; Amant F; D'hooghe T; Paridaens R
    J Clin Oncol; 2006 Nov; 24(33):5335-6; author reply 5337-8. PubMed ID: 17114672
    [No Abstract]   [Full Text] [Related]  

  • 26. [Persistent chylothorax in patient with lymphangioleiomyomatosis].
    Palmeiro R; Arosa V; Cuerda C; Bretón I; Camblor M; Rodríguez MC; García Peris P
    Nutr Hosp; 2012; 27(3):940-2. PubMed ID: 23114958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?
    Pickles T; Hamm J; Morris WJ; Schreiber WE; Tyldesley S
    BJU Int; 2012 Dec; 110(11 Pt B):E500-7. PubMed ID: 22564197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormone therapy for breast cancer].
    Saito Y; Suzuki Y; Tokuda Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():543-8. PubMed ID: 17682208
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis.
    Barrera P; Simons SO; Luijk B; Wessels MJ; Heijdra YF
    Ann Am Thorac Soc; 2013 Aug; 10(4):408-9. PubMed ID: 23952870
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intermittent androgen deprivation treatment of prostate cancer restarted at low level of serum prostate specific antigen: a pilot study].
    Maekawa S; Maegawa M; Ushida H; Inoue K; Kaneko Y; Ohmori K; Nishimura K
    Hinyokika Kiyo; 2001 Aug; 47(8):553-5. PubMed ID: 11579594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adverse reaction of LH-RH agonist and its countermeasure].
    Oishi K
    Nihon Rinsho; 2000 Jul; 58 Suppl():202-5. PubMed ID: 11022714
    [No Abstract]   [Full Text] [Related]  

  • 32. Randomised crossover trial to assess the tolerability of LHRH analogue administration.
    Williams G; Lindsay S; Bowsher WG
    Prostate Cancer Prostatic Dis; 2003; 6(2):187-9. PubMed ID: 12806381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refractory chylothorax after lung transplantation for lymphangioleiomyomatosis successfully cured with instillation of povidone.
    Dauriat G; Brugière O; Mal H; Camuset J; Castier Y; Lesèche G; Fournier M
    J Thorac Cardiovasc Surg; 2003 Sep; 126(3):875-7. PubMed ID: 14502176
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bone loss induced by GnRH agonist treatment].
    Onoe Y; Ohta H
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():702-5. PubMed ID: 15035212
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphangioleiomyomatosis.
    Kitaichi M; Izumi T
    Curr Opin Pulm Med; 1995 Sep; 1(5):417-24. PubMed ID: 9363104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics, effects, side effects of the LH-RH agonist].
    Miyanaga N; Akaza H
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():177-81. PubMed ID: 12599567
    [No Abstract]   [Full Text] [Related]  

  • 37. Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
    Pollack A; Horwitz EM
    Nat Clin Pract Oncol; 2005 Jan; 2(1):12-3. PubMed ID: 16264846
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist].
    Desurmont S; Bauters C; Copin MC; Dewailly D; Tonnel AB; Wallaert B
    Rev Mal Respir; 1996 Jul; 13(3):300-4. PubMed ID: 8765924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Are all LH-RH analogues equally effective in prostate cancer?].
    Fosså SD
    Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2493-5. PubMed ID: 16186869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Total androgen blockade--concept, theory, method and clinical application].
    Ozono S; Hirao Y
    Nihon Rinsho; 1998 Aug; 56(8):2129-34. PubMed ID: 9750521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.